Type-5 phosphodiesterase inhibitors
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Type-5 phosphodiesterase inhibitors, covering 2010-03-16 to 2010-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension [NA]